Review article · 2022 · Open access

Advances in hPSC expansion towards therapeutic entities: A review

Shelly E. Tannenbaum, Benjamin E. Reubinoff

Cell Proliferation, 55(8), e13247 · Published 31 May 2022 · DOI 10.1111/cpr.13247

Open full textCite this paper

In brief

“Advances in hPSC expansion towards therapeutic entities: A review” is a 2022 review article by Shelly E. Tannenbaum and Benjamin E. Reubinoff, published in Cell Proliferation. OpenAlex counts 34 citations as of 21 November 2026, which puts it in the top 8% of works published in 2022 by citations. It is open access under a CC BY licence: the full text is free to read at Cell Proliferation.

Citations
34
Most cited in
2024 (12)
Field-weighted impact
0.59
References
46
Authors
2

Abstract

For use in regenerative medicine, large-scale manufacturing of human pluripotent stem cells (hPSCs) under current good manufacturing practice (cGMPs) is required. Much progress has been made since culturing under static two-dimensional (2D) conditions on feeders, including feeder-free cultures, conditioned and xeno-free media, and three-dimensional (3D) dynamic suspension expansion. With the advent of horizontal-blade and vertical-wheel bioreactors, scale-out for large-scale production of differentiated hPSCs became possible; control of aggregate size, shear stress, fluid hydrodynamics, batch-feeding strategies, and other process parameters became a reality. Moving from substantially manipulated processes (i.e., 2D) to more automated ones allows easer compliance to current good manufacturing practices (cGMPs), and thus easier regulatory approval. Here, we review the current advances in the field of hPSC culturing, advantages, and challenges in bioreactor use, and regulatory areas of concern with respect to these advances. Manufacturing trends to reduce risk and streamline large-scale manufacturing will bring about easier, faster regulatory approval for clinical applications.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Tannenbaum, S. E., & Reubinoff, B. E. (2022). Advances in hPSC expansion towards therapeutic entities: A review. Cell Proliferation, 55(8), e13247. https://doi.org/10.1111/cpr.13247

MLA 9

Tannenbaum, Shelly E., and Benjamin E. Reubinoff. “Advances in hPSC expansion towards therapeutic entities: A review.” Cell Proliferation, vol. 55, no. 8, 2022, p. e13247. https://doi.org/10.1111/cpr.13247.

Chicago

Tannenbaum, Shelly E. and Benjamin E. Reubinoff. 2022. “Advances in hPSC expansion towards therapeutic entities: A review.” Cell Proliferation 55 (8): e13247. https://doi.org/10.1111/cpr.13247.

Harvard

Tannenbaum, S. E. and Reubinoff, B. E. (2022) ‘Advances in hPSC expansion towards therapeutic entities: A review’, Cell Proliferation, 55(8), p. e13247. doi:10.1111/cpr.13247.

IEEE

S. E. Tannenbaum and B. E. Reubinoff, “Advances in hPSC expansion towards therapeutic entities: A review,” Cell Proliferation, vol. 55, no. 8, p. e13247, 2022, doi: 10.1111/cpr.13247.

BibTeX

@article{tannenbaum2022advances,
  title     = {{Advances in hPSC expansion towards therapeutic entities: A review}},
  author    = {Tannenbaum, Shelly E. and Reubinoff, Benjamin E.},
  journal   = {Cell Proliferation},
  year      = {2022},
  volume    = {55},
  number    = {8},
  pages     = {e13247},
  doi       = {10.1111/cpr.13247},
  url       = {https://doi.org/10.1111/cpr.13247}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202222
202355
20241212
202566
202699

Its field-weighted citation impact is 0.59: it has been cited 0.59 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research

  • human pluripotent stem cells
  • large-scale cell expansion
  • current good manufacturing practice
  • feeder-free culture
  • conditioned medium
  • suspension culture
  • bioreactor scale-up
  • shear stress

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Tannenbaum, S. E., & Reubinoff, B. E. (2022). Advances in hPSC expansion towards therapeutic entities: A review. Cell Proliferation, 55(8), e13247. https://doi.org/10.1111/cpr.13247

How many times has this paper been cited?

34 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Cell Proliferation: sign in and open the full text from this page.

Who wrote this paper?

Shelly E. Tannenbaum, Benjamin E. Reubinoff.

What is the DOI of this paper?

10.1111/cpr.13247, permanently at https://doi.org/10.1111/cpr.13247. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.